Differing shapes of 1α,25-dihydroxyvitamin D3 function as ligands for the D-binding protein, nuclear receptor and membrane receptor: A status report
暂无分享,去创建一个
S. Zanello | R. Bouillon | A. Norman | W. Okamura | D. Satchell | E. D. Collins | J. Bishop | M. C. Dormanen | M. Farach-Carson | E. Seo | Eun-Gyoung Seo
[1] R. Bouillon,et al. Structure-function relationships in the vitamin D endocrine system. , 1995, Endocrine reviews.
[2] M. B. Kelly,et al. Direct Activation of Protein Kinase C by 1α,25-Dihydroxyvitamin D3(*) , 1995, The Journal of Biological Chemistry.
[3] R. Taussig,et al. Mammalian Membrane-bound Adenylyl Cyclases (*) , 1995, The Journal of Biological Chemistry.
[4] M. Holick,et al. Binding characteristics of a membrane receptor that recognizes 1α25‐dihydroxyvitamin D3 and its epimer, 1β,25‐dihydroxyvitamin D3 , 1994 .
[5] A. Norman,et al. Identification of a specific binding protein for 1 alpha,25-dihydroxyvitamin D3 in basal-lateral membranes of chick intestinal epithelium and relationship to transcaltachia. , 1994, The Journal of biological chemistry.
[6] M. Bissonnette,et al. 1,25(OH)2 vitamin D3 activates PKC-alpha in Caco-2 cells: a mechanism to limit secosteroid-induced rise in [Ca2+]i. , 1994, The American journal of physiology.
[7] A. Norman,et al. Profile of ligand specificity of the vitamin D binding protein for 1α,25‐dihydroxyvitamin d3 and its analogs , 1994, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[8] R. Wali,et al. The role of protein kinase-C alpha in the activation of particulate guanylate cyclase by 1 alpha,25-dihydroxyvitamin D3 in CaCo-2 cells. , 1994, Endocrinology.
[9] A. Norman,et al. Nonnuclear effects of the steroid hormone 1 alpha,25(OH)2-vitamin D3: analogs are able to functionally differentiate between nuclear and membrane receptors. , 1994, Biochemical and biophysical research communications.
[10] R. Bouillon,et al. Vitamin D, a pluripotent steroid hormone: structural studies, molecular endocrinology and clinical applications , 1994 .
[11] R. Bouillon,et al. Demonstration that 1 beta,25-dihydroxyvitamin D3 is an antagonist of the nongenomic but not genomic biological responses and biological profile of the three A-ring diastereomers of 1 alpha,25-dihydroxyvitamin D3. , 1993, The Journal of biological chemistry.
[12] W. Okamura,et al. Effect of C2O stereochemistry on the conformational profile of the side chains of vitamin D analogs. , 1993 .
[13] R. Bouillon,et al. Structure-function studies of 1,25-dihydroxyvitamin D3 and the vitamin D endocrine system. 1,25-dihydroxy-pentadeuterio-previtamin D3 (as a 6-s-cis analog) stimulates nongenomic but not genomic biological responses. , 1993, The Journal of biological chemistry.
[14] A. Norman,et al. The role of the vitamin D endocrine system in avian bone biology. , 1993, The Journal of nutrition.
[15] F. Coe,et al. Disorders of bone and mineral metabolism , 1992 .
[16] J. Palenzuela,et al. Vitamin D: Structure‐function analyses and the design of analogs , 1992, Journal of cellular biochemistry.
[17] A. Norman,et al. 1,25‐Dihydroxyvitamin D3 analog structure‐function assessment of the rapid stimulation of intestinal calcium absorption (transcaltachia) , 1992, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[18] A. C. Maiyar,et al. 1,25(OH)2-vitamin D3, a steroid hormone that produces biologic effects via both genomic and nongenomic pathways , 1992, The Journal of Steroid Biochemistry and Molecular Biology.
[19] A. C. Maiyar,et al. Vitamin D-mediated gene expression. , 1992, Critical reviews in eukaryotic gene expression.
[20] G. Stein,et al. 1α,25‐Dihydroxyvitamin D3 rapidly increases cytosolic calcium in clonal rat osteosarcoma cells lacking the vitamin D Receptor , 1991 .
[21] A. Norman,et al. Nongenomic actions of 1,25-dihydroxyvitamin D3 in rat osteosarcoma cells: structure-function studies using ligand analogs. , 1991, Endocrinology.
[22] A. R. Boland,et al. Influx of extracellular calcium mediates 1,25-dihydroxyvitamin D3-dependent transcaltachia (the rapid stimulation of duodenal Ca2+ transport). , 1990, Endocrinology.
[23] M. Holick,et al. 1α,25‐dihydroxyvitamin D3‐induced increments in hepatocyte cytosolic calcium and lysophosphatidylinositol: Inhibition by pertussis toxin and 1ß,25‐dihydroxyvitamin D3 , 1990 .
[24] A. R. de Boland,et al. Ca2(+)-channel agonist BAY K8644 mimics 1,25(OH)2-vitamin D3 rapid enhancement of Ca2+ transport in chick perfused duodenum. , 1990, Biochemical and biophysical research communications.
[25] M. Holick,et al. Rapid actions of 1α,25‐dihydroxyvitamin D3 on Ca2+ and phospholipids in isolated rat liver nuclei , 1989, FEBS letters.
[26] M. Farach-Carson,et al. Vitamin D3 metabolites modulate dihydropyridine-sensitive calcium currents in clonal rat osteosarcoma cells. , 1989, The Journal of biological chemistry.
[27] H. Koeffler,et al. The role of the vitamin D endocrine system in health and disease. , 1989, The New England journal of medicine.
[28] A. Norman,et al. 1,25(OH)2‐Vitamin D3 receptors: gene regulation and genetic circuitry , 1988, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[29] A. Norman,et al. 1,25-Dihydroxyvitamin D3-mediated intestinal calcium transport. Biochemical identification of lysosomes containing calcium and calcium-binding protein (calbindin-D28K). , 1986, The Journal of biological chemistry.
[30] Y. Yoshimoto,et al. Calcium transport in perfused duodena from normal chicks: enhancement within fourteen minutes of exposure to 1,25-dihydroxyvitamin D3. , 1984, Endocrinology.
[31] L. Orci,et al. The vitamin D endocrine system: steroid metabolism, hormone receptors, and biological response (calcium binding proteins). , 1982, Endocrine reviews.
[32] H. DeLuca. Metabolism of Vitamin D , 1979 .
[33] S. Sine,et al. Vitamin D in Solution: Conformations of Vitamin D3, α,25-Dihydroxyvitamin D3, and Dihydrotachysterol3 , 1974, Science.